| ACEi | Angiotensin-converting enzyme inhibitor |
| AF | Atrial fibrillation |
| AHF | Acute heart failure |
| AKI | Acute kidney injury |
| ALP | Alkaline phosphatase |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| ARB | Angiotensin receptor blocker |
| ARNI | Angiotensin receptor–neprilysin inhibitor |
| BP | Blood pressure |
| CABG | Coronary artery bypass grafting |
| CFS | Clinical Frailty Scale |
| C-index | Harrell concordance index |
| CI | Confidence interval |
| CRP | C-reactive protein |
| E/e′ | Ratio of early mitral inflow to early diastolic mitral annular velocity |
| ED | Emergency department |
| EF | Ejection fraction |
| ESC | European Society of Cardiology |
| GFR | Glomerular filtration rate |
| GGT | Gamma-glutamyl transferase |
| HbA1c | Glycated hemoglobin |
| HDL | High-density lipoprotein cholesterol |
| HF | Heart failure |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| HR | Hazard ratio |
| ICD | Implantable cardioverter-defibrillator |
| IQR | Interquartile range |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| LAVi | Left atrial volume index |
| LDL | Low-density lipoprotein cholesterol |
| LV | Left ventricular |
| LVEF | Left ventricular ejection fraction |
| MRA | Mineralocorticoid receptor antagonist |
| NT-proBNP | N-terminal pro–B-type natriuretic peptide |
| NYHA | New York Heart Association |
| PASP | Pulmonary artery systolic pressure |
| RDW | Red cell distribution width |
| RRT | Renal replacement therapy |
| RV | Right ventricular |
| SD | Standard deviation |
| SGLT2i | Sodium–glucose cotransporter-2 inhibitor |
| TAPSE | Tricuspid annular plane systolic excursion |
| TIA | Transient ischemic attack |
| TSH | Thyroid-stimulating hormone |
| WBC | White blood cell count |
| WRF | Worsening renal function |